ABSTRACT Group B Streptococcus (GBS) is a pervasive neonatal pathogen accounting for
a combined half a million deaths and stillbirths annually. The most common source of fetal or …

Abstract Background Group B streptococcal (GBS) infection remains one of the most
significant causes of late-onset sepsis and meningitis (LOGBS) among young infants …

The limited reserves of neutrophils are implicated in the susceptibility to infection in
neonates, however the regulation of neutrophil kinetics in infections in early life remains …

Group B Streptococcus (GBS) is a common intestinal colonizer during the neonatal period,
but also may cause late-onset sepsis or meningitis in up to 0.5% of otherwise healthy …

Abstract Group B Streptococcus (GBS) is a major cause of neonatal morbidity and mortality.
Serbia has not fully implemented preventive measures against GBS neonatal diseases …

Abstract Background Group B Streptococcus (GBS) is the leading cause of invasive
neonatal infection worldwide. In high-income countries mortality rates are 4–10%, and …

Group B Streptococcus (GBS) is a gram-positive bacterium that is harmless for healthy
individuals but may provoke invasive disease in young infants and immunocompromised …

Background: Group B Streptococcus (GBS) infection is the leading cause of neonatal
morbidity and mortality worldwide. This study aims to investigate the incidence of invasive …

Group B streptococcus (GBS) is a leading cause of serious neonatal infections. Maternal
GBS colonization is associated with early-and late-onset neonatal disease (EOD/LOD). In …

The aim of this work was to determine the susceptibility, molecular profile, and clonal
relationship in Streptococcus agalactiae (group B Streptococcus [GBS]) isolated from …